rs150129110
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001353921.2(ARHGEF9):c.582C>T(p.His194=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000029 in 1,206,552 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001353921.2 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGEF9 | NM_001353921.2 | c.582C>T | p.His194= | splice_region_variant, synonymous_variant | 4/10 | ENST00000671741.2 | NP_001340850.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF9 | ENST00000671741.2 | c.582C>T | p.His194= | splice_region_variant, synonymous_variant | 4/10 | NM_001353921.2 | ENSP00000500715 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000719 AC: 8AN: 111218Hom.: 0 Cov.: 22 AF XY: 0.0000299 AC XY: 1AN XY: 33458
GnomAD3 exomes AF: 0.0000910 AC: 16AN: 175856Hom.: 0 AF XY: 0.0000490 AC XY: 3AN XY: 61242
GnomAD4 exome AF: 0.0000246 AC: 27AN: 1095334Hom.: 0 Cov.: 30 AF XY: 0.0000194 AC XY: 7AN XY: 361294
GnomAD4 genome AF: 0.0000719 AC: 8AN: 111218Hom.: 0 Cov.: 22 AF XY: 0.0000299 AC XY: 1AN XY: 33458
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 08, 2016 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 19, 2016 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 13, 2020 | - - |
Developmental and epileptic encephalopathy, 8 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 06, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at